1. General Understanding of Disease

Understanding the state of knowledge of pathogenesis of IBD, and the principles underlying treatment


Full content only available after log-in


1.1. Knows the science underlying the pathogenesis of IBD, in particular relating to genetic and environmental factors involved, and differences between ulcerative colitis (UC) , Crohn’s disease (CD) and IBD unclassified

1.2. Understands the natural history of UC and Crohn’s disease, including its variability and the impact of therapy on the natural history

1.3. Understands the importance of communicating with patients and educating them about their disease and its natural history as well as the principals of management

1.4. Understands the basic immunology of IBD and mechanism of action (as far as it is understood) and rationale for using different treatment types in IBD

1.5. Able to use knowledge of modifiable and non-modifiable risk factors to underlie management decisions and to stratify risk for patients


        
 
Topic:





Programme Phase:



Content Format:








Page: () 1 2 3 4 5 6 7

Topic 1.1; 1.4 :

What causes IBD?

I. Cleynen

ECCO'18 Vienna

PPT
 


Topic 1.2 :

The role of pharmacoepidemiology in regulatory agencies

V. Stramann

ECCO'18 Vienna

PPT
 


Topic 1.2 :

Pharmacoepidemiological studies on IBD using national registries. Examples from France

L. Beaugerie

ECCO'18 Vienna

Webcast + PPT
 


Topic 1.2 :

Fat and inflammation in obesity

A. Schrmann

ECCO'18 Vienna

PPT
 


Topic 1.2 :

How is IBD care organised?

J. Halfvarson

ECCO'18 Vienna

PPT
 


Topic 1.2 :

Mesenteric fat and immune regulation - can abdominal fat control intestinal inflammation

B. Siegmund

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Abstract 4: Validation of a novel xenograft mouse model for intestinal fistulas

R. Bruckner

ECCO'18 Vienna

PPT
 


Topic 1.1 :

Application and relevance of in vivo models in IBD

C. Fiocchi

ECCO'18 Vienna

PPT
 


Page: () 1 2 3 4 5 6 7